Patients with mitral and tricuspid valve regurgitation, a condition sometimes called "leaky heart valves," appeared to do better after two
Home ยป
Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows
The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to
Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients
Collaborative international clinical trials testing full dose anticoagulation with heparin (a blood thinner) in both moderately ill and critically ill
New clinical trial to test possible therapeutics for COVID-19 in hospitalized patients
The Clinical Trials Network of Tennessee (CTN2) at the University of Tennessee Health Science Center has contracted a new clinical
Study evaluates stem cells' ability to prevent major cause of death in preterm infants
A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way
VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor
Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of
Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five